BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 15342982)

  • 1. A Critical Evaluation of Enoxaparin Dose Adjustment Guidelines in Children.
    Dinh CN; Moffett BS; Galati M; Lee-Kim Y; Yee DL; Mahoney D
    J Pediatr Pharmacol Ther; 2019; 24(2):128-133. PubMed ID: 31019405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability and Sterility of Enoxaparin 8 mg/mL Subcutaneous Injectable Solution.
    Moffett BS; Dinh K; Placencia J; Pelkey G; Hui SR; Teruya J
    J Pediatr Pharmacol Ther; 2016; 21(4):322-326. PubMed ID: 27713671
    [No Abstract]   [Full Text] [Related]  

  • 3. Lovenox Induced Tissue Necrosis, a Case Report and Literature Review.
    Issa AA; Simman R
    J Am Coll Clin Wound Spec; 2013 Dec; 5(3):66-8. PubMed ID: 26199895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Enoxaparin Dosing and Monitoring in Pediatric Patients at Children's Teaching Hospital.
    McCormick EW; Parbuoni KA; Huynh D; Morgan JA
    J Pediatr Pharmacol Ther; 2015; 20(1):33-6. PubMed ID: 25859168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of anticoagulants in paediatric patients.
    Yee DL; O'Brien SH; Young G
    Clin Pharmacokinet; 2013 Nov; 52(11):967-80. PubMed ID: 23797535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients.
    Fung LS; Klockau C
    J Pediatr Pharmacol Ther; 2010 Apr; 15(2):119-25. PubMed ID: 22477802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Monagle P; Chan AKC; Goldenberg NA; Ichord RN; Journeycake JM; Nowak-Göttl U; Vesely SK
    Chest; 2012 Feb; 141(2 Suppl):e737S-e801S. PubMed ID: 22315277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, efficacy, and safety of LMWHs in venous thrombosis and stroke in neonates, infants and children.
    Nowak-Göttl U; Bidlingmaier C; Krümpel A; Göttl L; Kenet G
    Br J Pharmacol; 2008 Mar; 153(6):1120-7. PubMed ID: 17906688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxaparin therapy for arterial thrombosis in infants with congenital heart disease.
    Bontadelli J; Moeller A; Schmugge M; Schraner T; Kretschmar O; Bauersfeld U; Bernet-Buettiker V; Albisetti M
    Intensive Care Med; 2007 Nov; 33(11):1978-84. PubMed ID: 17554520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosing and monitoring of enoxaparin therapy in children: experience in a tertiary care hospital.
    Andrade-Campos MM; Montes-Limón AE; Fernandez-Mosteirin N; Salvador-Osuna C; Torres M; Lucia-Cuesta JF; Rubio-Felix D
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):194-8. PubMed ID: 23358201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enoxaparin use in the neonatal intensive care unit: experience over 8 years.
    Malowany JI; Knoppert DC; Chan AK; Pepelassis D; Lee DS
    Pharmacotherapy; 2007 Sep; 27(9):1263-71. PubMed ID: 17723080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do neonates, infants and young children need a higher dose of enoxaparin in the cardiac intensive care unit?
    Sanchez de Toledo J; Gunawardena S; Munoz R; Orr R; Berry D; Sonderman S; Krallman S; Shiderly D; Wang L; Wearden P; Morell VO; Chrysostomou C
    Cardiol Young; 2010 Apr; 20(2):138-43. PubMed ID: 20199704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of enoxaparin dosing requirements in infants and children. Better dosing to achieve therapeutic levels.
    Bauman ME; Belletrutti MJ; Bajzar L; Black KL; Kuhle S; Bauman ML; Patricia Massicotte M
    Thromb Haemost; 2009 Jan; 101(1):86-92. PubMed ID: 19132193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of published pediatric dosage guidelines for enoxaparin: a retrospective review.
    Ho SH; Wu JK; Hamilton DP; Dix DB; Wadsworth LD
    J Pediatr Hematol Oncol; 2004 Sep; 26(9):561-6. PubMed ID: 15342982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective evaluation of antithrombin III supplementation in neonates and infants receiving enoxaparin for treatment of thrombosis.
    Corder A; Held K; Oschman A
    Pediatr Blood Cancer; 2014 Jun; 61(6):1063-7. PubMed ID: 24375987
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.